SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technical analysis for shorts & longs -- Ignore unavailable to you. Want to Upgrade?

To: Johnny Canuck who wrote (27961)9/6/2000 12:36:00 PM
From: Johnny Canuck  Respond to of 69956
 
Biotech news;

10:26 ET Boston Life Sciences (BLSI) 9 3/16 +1 (+12.2%): Reports that researchers in its Central Nervous System program have demonstrated that Inosine treatment apparently produced near total recovery of limb function in an experimental rat model of stroke

07:46 ET Immunogen, Inc. (IMGN) 17 7/8: Forms collaboration providing Abgenix (ABGX) with access to ImmunoGen's maytansinoid Tumor-Activated Prodrug (TAP) technology. Abgenix also to purchase $15 mln of ImmunoGen common stock at $19 per share.
18.



To: Johnny Canuck who wrote (27961)9/6/2000 12:43:46 PM
From: Suresh  Read Replies (2) | Respond to of 69956
 
Harry,

do you follow FIBR ? I took a small position when they pushed it down earlier.

Later,

Suresh


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News